Litcius/Paper detail

SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1

Liyan Sui, Yinghua Zhao, Wenfang Wang, Ping Wu, Zedong Wang, Yang Yu, Zhijun Hou, Guangyun Tan, Quan Liu

2021Frontiers in Immunology153 citationsDOIOpen Access PDF

Abstract

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative pathogen of current COVID-19 pandemic, and insufficient production of type I interferon (IFN-I) is associated with the severe forms of the disease. Membrane (M) protein of SARS-CoV-2 has been reported to suppress host IFN-I production, but the underlying mechanism is not completely understood. In this study, SARS-CoV-2 M protein was confirmed to suppress the expression of IFNβ and interferon-stimulated genes induced by RIG-I, MDA5, IKKϵ, and TBK1, and to inhibit IRF3 phosphorylation and dimerization caused by TBK1. SARS-CoV-2 M could interact with MDA5, TRAF3, IKKϵ, and TBK1, and induce TBK1 degradation via K48-linked ubiquitination. The reduced TBK1 further impaired the formation of TRAF3–TANK–TBK1-IKKε complex that leads to inhibition of IFN-I production. Our study revealed a novel mechanism of SARS-CoV-2 M for negative regulation of IFN-I production, which would provide deeper insight into the innate immunosuppression and pathogenicity of SARS-CoV-2.

Topics & Concepts

TANK-binding kinase 1InterferonIRF3UbiquitinIκB kinaseMDA5Interferon type IPhosphorylationBiologyRIG-ITRIFInnate immune systemVirologyCell biologyChemistryProtein degradationSignal transductionImmunologyNF-κBGeneBiochemistryProtein kinase ARNAImmune systemRNA interferenceToll-like receptorMitogen-activated protein kinase kinaseinterferon and immune responsesViral Infections and VectorsSARS-CoV-2 and COVID-19 Research